Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Lupat

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biodata Mining|October 30, 2025
Using artificial intelligence (AI) to model clinical variant reporting for next generation sequencing (NGS) oncology assaysKenneth D Doig, Rashindrie Perera, Yamuna Kankanige, et al.
Urologic Oncology|November 21, 2015
Searching for candidate genes in familial BRCAX mutation carriers with prostate cancerSally M Hunter, Simone M Rowley, David Clouston, et al.
BMC Research Notes|July 24, 2020
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumoursSally M Hunter, Genevieve V Dall, Maria A Doyle, et al.
Computational and Structural Biotechnology Journal|December 1, 2025
macpie: Scalable workflow for high-throughput transcriptomic profilingNenad Bartonicek, Xin Liu, Laura Twomey, et al.
Bioinformatics (Oxford, England)|April 5, 2012
CONTRA: copy number analysis for targeted resequencingJason Li, Richard Lupat, Kaushalya C Amarasinghe, et al.
Breast Cancer Research : BCR|January 11, 2018
Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPsNa Li, Simone M Rowley, Ella R Thompson, et al.
Scientific Reports|April 25, 2019
CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencingJohn F Markham, Satwica Yerneni, Georgina L Ryland, et al.
Scientific Reports|June 25, 2020
Publisher Correction: CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencingJohn F Markham, Satwica Yerneni, Georgina L Ryland, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
Breast Cancer Research : BCR|August 19, 2015
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controlsElla R Thompson, Kylie L Gorringe, Simone M Rowley, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biodata Mining|October 30, 2025
Using artificial intelligence (AI) to model clinical variant reporting for next generation sequencing (NGS) oncology assaysKenneth D Doig, Rashindrie Perera, Yamuna Kankanige, et al.
Urologic Oncology|November 21, 2015
Searching for candidate genes in familial BRCAX mutation carriers with prostate cancerSally M Hunter, Simone M Rowley, David Clouston, et al.
BMC Research Notes|July 24, 2020
Molecular comparison of pure ovarian fibroma with serous benign ovarian tumoursSally M Hunter, Genevieve V Dall, Maria A Doyle, et al.
Computational and Structural Biotechnology Journal|December 1, 2025
macpie: Scalable workflow for high-throughput transcriptomic profilingNenad Bartonicek, Xin Liu, Laura Twomey, et al.
Bioinformatics (Oxford, England)|April 5, 2012
CONTRA: copy number analysis for targeted resequencingJason Li, Richard Lupat, Kaushalya C Amarasinghe, et al.
Breast Cancer Research : BCR|January 11, 2018
Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPsNa Li, Simone M Rowley, Ella R Thompson, et al.
Scientific Reports|April 25, 2019
CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencingJohn F Markham, Satwica Yerneni, Georgina L Ryland, et al.
Scientific Reports|June 25, 2020
Publisher Correction: CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencingJohn F Markham, Satwica Yerneni, Georgina L Ryland, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
Breast Cancer Research : BCR|August 19, 2015
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controlsElla R Thompson, Kylie L Gorringe, Simone M Rowley, et al.
Pageof 2